2024 AMCP CME Symposium - Exploring the Impact of Intravenous Iron for Iron Deficiency in Heart Failure

HAZLET, N.J. - March 26, 2024 - PRLog -- In this program, experts in ID in HF will explain to attendees key concepts of ID pathophysiology, identify the tests for diagnosis of ID and emphasize the importance of regular screening. Evidence with IV iron and guideline recommendations will be translated to clinical practice, illustrating the value of treating HF patients with ID with IV iron. The case will demonstrate the benefits of IV iron for HF patients with ID—making them feel better (improving their HF symptoms, exercise capacity, and overall quality of life (QOL)) and keeping them out of the hospital. The case will align with an expert-generated algorithm published in a scientific statement on ID in HF from the Heart Failure Society of America (HFSA).

Click here for more information

CHAIR

Gregory Lewis, MD
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

FACULTY

Stormi Gale, PharmD
Heart and Vascular Institute
Novant Health
Huntersville, North Carolina

Rajeev Malhotra, MD, MS
Assistant Professor of Medicine
Harvard Medical School
Boston, Massachusetts

This educational activity is intended for managed care pharmacists.

This activity is supported by an independent educational grant from American Regent.

Pharmacists: Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE). This activity is accredited for 1.5 contact hours of application-based CPE under the ACPE universal activity number 0430-9999-24-030-L01-P.

This is a complimentary event. Registration does not guarantee seating. This event is designed for the education of pharmacists and improvement in the care of patients according to guidelines for care. Priority is given to pharmacists. We are unable to accommodate guests. For additional CME/CE activities visit www.CMEPlanet.com